Recro Pharma, Inc. 4
4 · Recro Pharma, Inc. · Filed Aug 3, 2016
Insider Transaction Report
Form 4
Myers Diane
Senior VP-Reg./Quality
Transactions
- Tax Payment
Common Stock
2016-08-01$9.70/sh−940$9,118→ 1,560 total - Exercise/Conversion
Common Stock
2016-08-01+2,500→ 2,500 total
Footnotes (1)
- [F1]On August 1, 2016, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,500 performance-based restricted stock units, which were converted into 2,500 shares of common stock on a one-for-one basis.